779
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Insights into the anti-inflammatory and anti-arthritic potential of 3-Acetyl-11-keto-β-Boswellic Acid as a therapeutic approach in Rheumatoid Arthritis

& ORCID Icon
Pages 867-871 | Received 30 Aug 2023, Accepted 09 Oct 2023, Published online: 19 Oct 2023

Figures & data

Figure 1. Chemical structure of 3-Acetyl-11-keto-β-boswellic acid (AKBA).

Figure 1. Chemical structure of 3-Acetyl-11-keto-β-boswellic acid (AKBA).

Figure 2. Diagrammatic illustration of signaling pathways and molecular targets of 3-Acetyl-11-keto-β-boswellic acid (AKBA) in rheumatoid arthritis. Abbreviations: AKBA: 3-Acetyl-11-keto-β-boswellic Acid; NF-κB: nuclear factor kappa B; IL: Interleukin; TNF-α: tumor necrosis factor-alpha; CD4: clusters of differentiation 4; RF: rheumatoid factors; APC: antigen-presenting cells; RANKL: receptor activator of nuclear factor-kappa B ligand; PLA2: phospholipase A2; FLAP: 5-lipoxygenase activating protein; 5-LOX: 5-lipoxygenase; LT (A4, B4, C4, D4, E4): leukotriene (A4, B4, C4, D4, E4).

Figure 2. Diagrammatic illustration of signaling pathways and molecular targets of 3-Acetyl-11-keto-β-boswellic acid (AKBA) in rheumatoid arthritis. Abbreviations: AKBA: 3-Acetyl-11-keto-β-boswellic Acid; NF-κB: nuclear factor kappa B; IL: Interleukin; TNF-α: tumor necrosis factor-alpha; CD4: clusters of differentiation 4; RF: rheumatoid factors; APC: antigen-presenting cells; RANKL: receptor activator of nuclear factor-kappa B ligand; PLA2: phospholipase A2; FLAP: 5-lipoxygenase activating protein; 5-LOX: 5-lipoxygenase; LT (A4, B4, C4, D4, E4): leukotriene (A4, B4, C4, D4, E4).

Table 1. 3-Acetyl-11-keto-β-boswellic acid (AKBA) loaded nanocarrier system for exploring its anti-inflammatory and anti-arthritic potential.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.